"#Diversity Action Plans To Improve Enrollment of Participants From  Underrepresented Populations in Clinical Studies; Draft Guidance for  Industry; Availability" A Notice by the Food and Drug Administration (#FDA) on 06/28/2024

#ClinicalTrials